Insic, Maximo B.
HRN: 07-81-91 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2025
AZITHROMYCIN 500MG TABLET (TAB)
02/01/2025
02/05/2025
ORAL
500mg
OD
TB Vs Peritoneal Carcinomatosis; Liver Cirrhosis; Cholecystolithiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes